HighTower Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $761K | Buy |
34,529
+22,359
| +184% | +$389K | ﹤0.01% | 2384 |
|
|
2025
Q4 | $143K | Buy |
12,170
+439
| +4% | +$5.64K | ﹤0.01% | 3453 |
|
|
2025
Q3 | $186K | Buy |
11,731
+843
| +8% | +$12.2K | ﹤0.01% | 3395 |
|
|
2025
Q2 | $125K | Buy |
+10,888
| New | +$123K | ﹤0.01% | 3424 |
|
|
2025
Q1 | – | Sell |
-12,236
| Closed | -$207K | – | 3790 |
|
|
2024
Q4 | $207K | Sell |
12,236
-2,784
| -19% | -$54.2K | ﹤0.01% | 3173 |
|
|
2024
Q3 | $300K | Buy |
15,020
+1,384
| +10% | +$28.3K | ﹤0.01% | 2811 |
|
|
2024
Q2 | $301K | Sell |
13,636
-5,490
| -29% | -$144K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $505K | Sell |
19,126
-219
| -1% | -$6.24K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $612K | Buy |
19,345
+1,130
| +6% | +$30.7K | ﹤0.01% | 2173 |
|
|
2023
Q3 | $514K | Sell |
18,215
-33,497
| -65% | -$1.15M | ﹤0.01% | 2217 |
|
|
2023
Q2 | $1.91M | Buy |
51,712
+3,347
| +7% | +$102K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $1.45M | Sell |
48,365
-193
| -0.4% | -$6.36K | ﹤0.01% | 1475 |
|
|
2022
Q4 | $1.49M | Sell |
48,558
-5,685
| -10% | -$171K | ﹤0.01% | 1445 |
|
|
2022
Q3 | $1.33M | Buy |
54,243
+2,279
| +4% | +$75.2K | ﹤0.01% | 1456 |
|
|
2022
Q2 | $1.67M | Sell |
51,964
-22,400
| -30% | -$824K | ﹤0.01% | 1356 |
|
|
2022
Q1 | $2.34M | Buy |
74,364
+6,132
| +9% | +$192K | 0.01% | 1277 |
|
|
2021
Q4 | $2.29M | Buy |
68,232
+8,865
| +15% | +$276K | 0.01% | 1290 |
|
|
2021
Q3 | $1.73M | Buy |
59,367
+2,957
| +5% | +$95.7K | ﹤0.01% | 1344 |
|
|
2021
Q2 | $1.96M | Buy |
56,410
+44,907
| +390% | +$1.49M | 0.01% | 1233 |
|
|
2021
Q1 | $322K | Buy |
11,503
+31
| +0.3% | +$825 | ﹤0.01% | 2248 |
|
|
2020
Q4 | $281K | Buy |
11,472
+134
| +1% | +$3.19K | ﹤0.01% | 1980 |
|
|
2020
Q3 | $237K | Sell |
11,338
-496
| -4% | -$9.57K | ﹤0.01% | 1976 |
|
|
2020
Q2 | $177K | Sell |
11,834
-441
| -4% | -$5.58K | ﹤0.01% | 2020 |
|
|
2020
Q1 | $103K | Sell |
12,275
-1,735
| -12% | -$25K | ﹤0.01% | 1933 |
|
|
2019
Q4 | $252K | Sell |
14,010
-1,979
| -12% | -$32.9K | ﹤0.01% | 1822 |
|
|
2019
Q3 | $237K | Sell |
15,989
-40,682
| -72% | -$662K | ﹤0.01% | 1946 |
|
|
2019
Q2 | $1.36M | Buy |
56,671
+7,277
| +15% | +$214K | 0.01% | 1057 |
|
|
2019
Q1 | $1.82M | Buy |
49,394
+27,777
| +128% | +$1.01M | 0.01% | 890 |
|
|
2018
Q4 | $607K | Buy |
21,617
+4,087
| +23% | +$129K | ﹤0.01% | 1259 |
|
|
2018
Q3 | $694K | Buy |
17,530
+492
| +3% | +$21.5K | 0.01% | 1299 |
|
|
2018
Q2 | $753K | Sell |
17,038
-529
| -3% | -$26.3K | 0.01% | 1259 |
|
|
2018
Q1 | $855K | Buy |
17,567
+1,003
| +6% | +$50.1K | 0.01% | 1154 |
|
|
2017
Q4 | $834K | Buy |
16,564
+1,073
| +7% | +$56.2K | 0.01% | 1205 |
|
|
2017
Q3 | $783K | Sell |
15,491
-1,276
| -8% | -$60.2K | 0.01% | 1216 |
|
|
2017
Q2 | $646K | Buy |
16,767
+3,705
| +28% | +$146K | 0.01% | 1258 |
|
|
2017
Q1 | $511K | Sell |
13,062
-751
| -5% | -$22.6K | ﹤0.01% | 1315 |
|
|
2016
Q4 | $292K | Sell |
13,813
-732
| -5% | -$15K | ﹤0.01% | 1484 |
|
|
2016
Q3 | $224K | Sell |
14,545
-374
| -3% | -$4.27K | ﹤0.01% | 1588 |
|
|
2016
Q2 | $99K | Sell |
14,919
-2,189
| -13% | -$19.5K | ﹤0.01% | 1601 |
|
|
2016
Q1 | $93K | Sell |
17,108
-7,497
| -30% | -$37.7K | ﹤0.01% | 1916 |
|
|
2015
Q4 | $93K | Sell |
24,605
-23,220
| -49% | -$148K | ﹤0.01% | 1849 |
|
|
2015
Q3 | $210K | Buy |
+47,825
| New | +$501K | ﹤0.01% | 1623 |
|
Other funds holding CC
VPM
VCM
WHCM
HighTower Advisors's CC Position: Q1 2026 in Review
HighTower Advisors increased its Chemours (CC) stake by 184% in Q1 2026, buying an estimated $389K and bringing the position to 34,529 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.
HighTower Advisors first reported a position in CC in Q3 2015 and has held it in 42 quarters since. The position peaked at $2.34M in Q1 2022. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- HighTower Advisors held 34,529 shares of Chemours worth $761K as of Q1 2026.
- HighTower Advisors bought 22,359 Chemours shares in Q1 2026, an estimated $389K.
- Chemours made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2384 holding.
- HighTower Advisors first reported a position in Chemours in Q3 2015 and has held it in 42 quarters since.
- HighTower Advisors's Chemours position peaked at $2.34M in Q1 2022.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.